Summary of findings 1: PLD with chemotherapy vs alternative combination chemotherapy
Neurological (grade ≥ 3) · platinum‐sensitive recurrent EOC
It is very uncertain whether summary of findings 1: PLD with chemotherapy changes neurological (grade ≥ 3) compared with alternative combination chemotherapy (very low certainty).
1 finding from 1 review
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyRR 0.38 [0.2, 0.74]4 studies · 1900 participantsVery low